Immune Design

... Read more

Immune Pharmaceuticals Signs Letter of Intent with Pint Pharma Regarding

... Read more

Immune Pharmaceuticals Announces the launch of REMAIN ™ , an

... Read more

ImmunoCellular Therapeutics Provides Update on ICT-107 Phase 3 Glioblastoma

... Read more

Takeda Licenses Rights to

... Read more

ImmunoGen’s Mirvetuximab Soravtansine (IMGN853) Demonstrates Notable Single Agent Activity for Patients with Platinum-Resistant

... Read more

Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and

... Read more

Immunomedics Delivers Business Updates, Announces Private Placement Offering

... Read more

Read more

Immunovaccine Announces Additional Positive Topline Results from Phase 1/1b

... Read more